Ross Nevin England, MD, PhD
Travel Medicine, Infectious Diseases
Accepting new patients
Sees patients of all ages
MacGregor Infection Medicine and Travel Program
Penn Medicine Provider

About me

  • Instructor A of Pediatrics

Education and training

  • Medical School: Temple University School of Medicine
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: Hospital of the University of Pennsylvania
  • Fellowship: Children's Hospital of Philadelphia

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. England is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Alemayehu T, England RN, Oguttu B, Jarovsky, D Should birth-dose vaccines for preterm newborns still be debated. , Int J Infect Dis, 154(1): 2025,107866


England RN, Drapeau EM, Alameh M-G, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model. , npj Vaccines, 9(1): 2024,110


England RN, Drapeau EM, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNALNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model , Hospital of the University of Pennsylvania, Department of Medicine Research Day, Philadelphia, PA, Podium: 2023


England RN, Drapeau EM, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNALNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model , Centers of Excellence for Influenza Research and Response Annual CEIRR Network Meeting, Baltimore, MD, Podium: 2023


England RN, Drapeau EM, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNALNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model , IDWeek, Boston, MA, Poster: 2023


Gabryszewski SJ, England RN, Sun D, Gentile TL, Hochgertel W, Jyonouchi S, Silverman M, Zaoutis T, Sullivan KE, Henrickson SE Self-Limited COVID-19 in a Patient with Artemis SCID. , J Clin Immunol, 41(8): 2021,1745-1747


Shields BE, Perelygina L, Samimi S, Haun P, Leung T, Abernathy E, Chen MH, Hao L, Icenogle J, Drolet B, Wilson B, Bryer JS, England R, Blumberg E, Wanat K, Sullivan K, Rosenbach M Granulomatous Dermatitis Associated with Rubella Virus Infection in an Adult with Immunode ciency. , JAMA Dermatol, 157(7): 2021,842-847


England R, Pak J, Liu M, Rao S, Azono O, Levy O, van Haren SD Human Blood Plasma Shapes Distinct Neonatal TLR-Mediated Dendritic Cell Activation via Expression of the Mi-croRNA Let-7g. , Immunohorizons, 5(4): 2021,246-256


Kulick-Soper CV, McKee JL, Wolf RL, Mohan S, Stein JM, Masur, JH, Lazor JW, Dunlap DG, McGinniss JE, David MZ, England RN, Rothstein A, Gelfand MA, Cucchiara BL, Davis KA. Pearls and Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19. , Neurology, 95(10): 2020,454-457


Gabunia K, Herman AB, Ray M, Kelemen SE, England RN, DeLa Cadena R, Foster WJ, Elliott KJ, Eguchi S, Autieri MV Induction of MiR133a Expression by IL-19 Targets LDLRAP1 and Reduces oxLDL Uptake in VSMC. , J Mol Cell Cardiol, 105(1): 2017,38-48